Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxymetazoline Absorption in Nasal Surgeries
NCT02453841Completed
- Start
- Dec 2015
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of oxymetazoline in chronic rhinosinusitis (CRS), Turbinate hypertrophy and adenoid hypertrophy (3 arms). Primary endpoints: Blood Pressure Following Oxymetazoline Administration and Heart Rate Following Oxymetazoline Administration. Started Dec 2015; status: completed.
02
Drugs
oxymetazoline
03
Conditions
chronic rhinosinusitis (CRS)Turbinate hypertrophyadenoid hypertrophy
Beyond the preview
Go deeper on NCT02453841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02453841.